- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03281109
The Effect of Menstrual Cycle On IL-6, TNF-α And Periodontal Status
The Effect of Menstrual Cycle on Periodontium
Aim: Women's menstrual cycle is controlled by the secretion of sex hormones. Sex steroid hormones are thought to be affect to periodontal tissues, wound healing, periodontal disease progression and bone turn over. The aim the study is to evaluate clinical periodontal parameters and interleukin- 6 (IL-6) and tumor necrosis factor alpha (TNF-α) levels in gingival crevicular fluid (GCF) in menstrual cycle.
Material and methods: Twenty-five patients were included in this study clinical periodontal parameters and levels of IL-6 and TNF α in gingival crevicular fluid were evaluated at three periods of menstrual cycle (menstruation day (MD)-ovulation day(OD)-premenstruation day (PmD)). Levels of IL-6 and TNF α in gingival crevicular fluid were determined by ELISA.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Population
Sixty women were initially included in this longitudinal, prospective study in Yuzuncu Yil University, Faculty of Dentistry, Department of Periodontology.
The procedure was accepted and informed consent was signed by all participants. The material and method used in the trial were accepted by the Yuzuncu Yil University Ethics Committee and were found to conform to the guidelines issued in the Declaration of Helsinki. To standardize the effect of plaque accumulation on the tested parameters, subjects were given oral hygiene instructions before the study.
Clinical Procedures, and Measurements
All subjects were scheduled for periodontal measurements and GCF sampling on the specific days determined as follows: 1) menstruation day (MD); on days 2-3 of menstruation 2) ovulation day (OD); detected by saliva fertility microscope 12-14 days of menstrual cycle and 3) premenstruation day (PmD); 22-24 days of menstruation cycle.
The subjects evaluated the study criteria in terms of the duration of a regular menstrual cycle (28 ± 3 d) and were followed up for three menstrual cycles. Five participants were excluded from the study if their menstrual cycles were longer or shorter than 28 ± 3 d for the last 12 months.
Donna ® Saliva Fertility Tester was used to detect the ovulation day. Patients also made their own fever measurement and confirmed the ovulation day. A small amount of saliva was placed onto microscope and after 5 minutes results were evaluated according to manufacturer's instructions. The outside of microscope lens cleaned with alcohol and a cotton swab after each use.
Periodontal measurements were performed for all patients at each of the three time points from index teeth. Periodontal measurements were: 1) plaque index (PI) (according to Silness and Löe index) 9: measured at six sites around each tooth; the highest score per tooth was recorded; 2) gingival index (GI) (according to Löe and Silness index) 10: measured at six sites around each tooth; the highest score per tooth was recorded; 3) probing depth (PD): measured at six sites around each tooth.
The GCF samples were obtained for 30 seconds from the mesiobuccal gingival sulcus of teeth using periodontal paper strips . The samples were taken 3 hours after the patients brush their teeth in the morning.
To avoid irritation of the periodontal pocket epithelium, the clinical measurements were obtained after the GCF samples collecting. The area was isolated with cotton rolls. All paper strips were stored in phosphate buffered solution. Paper points contaminated with blood and saliva were not used for study. GCF samples were stored at -80 °C for laboratory analyses. GCF samples were analyzed for IL-6 and TNF-α using commercially available sandwich enzyme-linked immunosorbent assay according to the manufacturer's instructions. Results were reported as concentrations of IL-6 and TNF-α in GCF.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
VAN, Turkey, 65080
- Yuzuncu Yıl University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:Inclusion criteria were:
- premenopausal women, age 20-35 to years;
- normal and steady menstrual cycle (25 to 31 days long);
- available for clinical examination;
- non-smoking;
- antibiotic therapy or use of nonsteroidal anti-inflammatory drugs within the past 6 months;
- healthy systemic status;
- normal body mass index;
- healthy periodontium.
Exclusion Criteria: Exclusion criteria were as follows:
- pregnancy;
- use of oral contraceptives;
- metabolic or systemic condition that might affect the periodontium;
- antibiotic therapy or use of nonsteroidal anti-inflammatory drugs within the past 6 months;
- periodontitis;
- smoking and
- with the diagnosis of polycystic over or hyperandrogenism according to Rotterdam diagnostic criteria
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
periodontal clinical parameters
Time Frame: 1 menstrual cycle (approximately 1 month) every patient follow up
|
gingival index: according to Silness and Löe gingival index plaque index: according to Löe and Silness plaque index probing depth the distance between gingival margin to periodontal sulcus bottom (mm) IL-6 concentration (pg/microliter) TNF- alpha concentration (pg/microliter)
|
1 menstrual cycle (approximately 1 month) every patient follow up
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: hacer sahin aydinyurt, yuzuncu yil universtiy
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- YuzuncuYıl4
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Menstrual Cycle-Associated Gingivitis
-
Taipei Medical University WanFang HospitalCompletedIrregular Menstrual Cycle | Regular Menstrual CycleTaiwan
-
University of BonnRadboud University Medical Center; University Hospital, BonnRecruiting
-
University of ArizonaCompletedMenstrual CycleUnited States
-
Necmettin Erbakan UniversityNot yet recruitingMenstrual Cycle
-
Istanbul Medipol University HospitalRecruiting
-
Universitat Jaume ICompleted
-
Wolfson Medical CenterUnknown
-
AbbottCompletedIrregular Menstrual CycleKazakhstan, Russian Federation, Ukraine, Uzbekistan
-
AbbottCompletedIrregular Menstrual CycleIndia
-
Fudan UniversityCompleted
Clinical Trials on diagnosis
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruiting
-
Singapore Chung Hwa Medical InstitutionMinistry of Health, SingaporeRecruitingHypertension | Healthy | Diabete Mellitus | Pre-diabetes | Dyslipidemia Associated With Type II Diabetes MellitusSingapore
-
Universidade do PortoSociedade Portuguesa de Alergologia e Imunologia ClinicaRecruitingAsthma | Rhinitis, AllergicPortugal
-
Hospices Civils de LyonActive, not recruiting
-
IsalaCompleted
-
Beijing Tiantan HospitalWest China Hospital; The First Affiliated Hospital of Zhengzhou University; Capital... and other collaboratorsNot yet recruiting
-
Yeditepe UniversityCompleted
-
US Department of Veterans AffairsCompleted
-
SimulConsult, Inc.UnknownEmpowering Physicians With Evidence-Based Decision Support for Pediatric Rheumatology (Rheumatology)RheumatologyUnited States
-
Fondation LenvalCompletedOtitis Media, SuppurativeFrance